Loading clinical trials...
Loading clinical trials...
This cross-sectional observational study investigates the relationship between climate change anxiety and chronic rhinosinusitis (CRS) symptom severity and quality of life (QoL) in adults. As climate change continues to influence public health, individuals with chronic respiratory diseases may experience worsened symptoms due to heightened psychological stress and perceived environmental instability. The study utilizes standardized instruments including the SNOT-22 (Sino-Nasal Outcome Test), a QoL scale, and a climate change anxiety questionnaire to evaluate associations among these variables.
Climate change has emerged as a major global health concern, with growing recognition of its psychological impacts, including anxiety, distress, and perceived environmental instability. These psychosocial effects may exacerbate symptoms in chronic inflammatory conditions such as Chronic Rhinosinusitis (CRS), a disease characterized by persistent nasal congestion, facial pressure, and impaired quality of life. This study aims to explore the correlation between self-perceived climate change anxiety and CRS symptom severity and QoL in an adult population. A total of 134 participants with CRS, aged ≥18 years, were recruited to complete an online Arabic-language survey. The survey included demographic information, the SNOT-22 scale, a validated quality of life questionnaire, and a climate change stress scale. The primary objective is to assess the association between climate change stress and symptom severity (SNOT-22 total score). The secondary objective is to determine the relationship between climate change anxiety and QoL. The study uses Pearson's correlation analysis to examine these associations. This research introduces a novel psychosomatic dimension to CRS management by highlighting how environmental and psychological stressors may influence disease burden. Results may inform multidisciplinary approaches for patient care, incorporating environmental awareness and mental health support.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Sinai university
Cairo, Egypt
Start Date
January 1, 2025
Primary Completion Date
June 25, 2025
Completion Date
July 25, 2025
Last Updated
August 13, 2025
134
ACTUAL participants
Lead Sponsor
Sinai University
NCT07383402
NCT07301580
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06671561